Retroperitoneal fibrosis associated with atenolol.
D001262:Atenolol / Q000009:adverse effects*; D055598:Chemical Phenomena; D002621:Chemistry; D006801:Humans; D011412:Propanolamines / Q000009:adverse effects*; D012185:Retroperitoneal Fibrosis / Q000139:chemically induced*
D011412:Propanolamines; D001262:Atenolol